Gemini Therapeutics Inc. (the company became a subdivision of the company Disc Medicine (NASDAQ : IRON)) (GMTX)
📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 12K shares of Disc Medicine, Inc. (at $93.60 each, total $1.2M) Filed: Dec 12, 2025 | ID: 056829
📋 Form 144 Filing: Atlas Venture Opportunity Fund II, LP
Company: Disc Medicine, Inc.
Filing Date: 2025-12-12
Relationship: Shareholder
Planned Sale Details:
Additional Information: